AU6066999A - Method for identifying atrial natriuretic peptide (anp) - Google Patents

Method for identifying atrial natriuretic peptide (anp)

Info

Publication number
AU6066999A
AU6066999A AU60669/99A AU6066999A AU6066999A AU 6066999 A AU6066999 A AU 6066999A AU 60669/99 A AU60669/99 A AU 60669/99A AU 6066999 A AU6066999 A AU 6066999A AU 6066999 A AU6066999 A AU 6066999A
Authority
AU
Australia
Prior art keywords
anp
natriuretic peptide
atrial natriuretic
identifying atrial
identifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60669/99A
Inventor
Albert Missbichler
Wolfgang Woloszczuk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomedica GmbH
Original Assignee
Biomedica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomedica GmbH filed Critical Biomedica GmbH
Publication of AU6066999A publication Critical patent/AU6066999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/58Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
AU60669/99A 1998-09-29 1999-09-28 Method for identifying atrial natriuretic peptide (anp) Abandoned AU6066999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT161898A AT407674B (en) 1998-09-29 1998-09-29 METHOD FOR DETERMINING ATRIAL NATRIURETIC PEPTIDE (ANP)
AT1618/98 1998-09-29
PCT/AT1999/000230 WO2000019207A2 (en) 1998-09-29 1999-09-28 Method for identifying atrial natriuretic peptide (anp)

Publications (1)

Publication Number Publication Date
AU6066999A true AU6066999A (en) 2000-04-17

Family

ID=3517316

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60669/99A Abandoned AU6066999A (en) 1998-09-29 1999-09-28 Method for identifying atrial natriuretic peptide (anp)

Country Status (3)

Country Link
AT (1) AT407674B (en)
AU (1) AU6066999A (en)
WO (1) WO2000019207A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4656493B2 (en) * 2002-11-20 2011-03-23 ベー・エル・アー・ハー・エム・エス・ゲーエムベーハー Sandwich immunoassay for identifying partial proANP peptides
GB2403533A (en) 2003-06-30 2005-01-05 Orion Corp Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof
DE102007022367A1 (en) * 2007-05-07 2008-11-20 B.R.A.H.M.S Ag Method for the determination of amino-terminal pro-ANP in overweight patients
JP2014210761A (en) * 2013-04-05 2014-11-13 株式会社シバヤギ Anti-canine n-terminal pro-atrial natriuretic peptide antibody and immunological measurement method using the same, and kit for immunological measurement
JP6961172B2 (en) * 2018-04-13 2021-11-05 共立製薬株式会社 Heart failure detection method, heart failure detection device, sandwich immunological measurement method, and antibody combination

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346953A1 (en) * 1983-12-24 1985-08-14 Organogen Medizinisch-Molekularbiologische Forschungsgesellschaft mbH, 6900 Heidelberg CARDIODILATIN, A NEW PEPTIDE HORMONE AND METHOD FOR THE PRODUCTION THEREOF
JPH0672155B2 (en) * 1984-08-24 1994-09-14 塩野義製薬株式会社 Polypeptide for producing α-hANP antiserum
CA1335082C (en) * 1987-09-01 1995-04-04 Hiroo Imura Monoclonal antibody recognizing –-hanp and a reagent for immunoassay of –-hanp
US5691310A (en) * 1987-09-29 1997-11-25 Vesely; David L. Methods of treatment using proANF peptides
JP2681370B2 (en) * 1988-06-30 1997-11-26 塩野義製薬株式会社 Immunoassay
JP2561513B2 (en) * 1988-07-04 1996-12-11 塩野義製薬株式会社 Monoclonal antibody that recognizes γ-ANP
JP2873586B2 (en) * 1988-07-15 1999-03-24 武田薬品工業株式会社 Antibody and immunochemical measurement method using the same
JPH0667319B2 (en) * 1989-04-19 1994-08-31 塩野義製薬株式会社 Monoclonal antibody that recognizes the C-terminal side of ANP
JPH0748071B2 (en) * 1989-05-31 1995-05-24 株式会社ミドリ十字 hANP antibody and immunoassay for hANP
US5366859A (en) * 1991-10-31 1994-11-22 Mitsubishi Petrochemical Co., Ltd. Radioimmunoassay method
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds

Also Published As

Publication number Publication date
WO2000019207A3 (en) 2000-06-08
ATA161898A (en) 2000-09-15
AT407674B (en) 2001-05-25
WO2000019207A2 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
AU1991599A (en) Method for transferring information
AU2035199A (en) Method for organizing information
AU2154699A (en) Method for guiding aircraft on taxiways
AU7540398A (en) A method for de novo peptide sequence determination
AU3035299A (en) Method for powder-coating
AU1432800A (en) Method for transferring information
AU6482498A (en) Substituted diaminocarboxylic acids
AU1670300A (en) Natriuretic peptide fragments
AU4942497A (en) Method for upgrading used sulfuric acids
AU6348399A (en) Method for preparing methionine
AU2452899A (en) Method for etching
AU8007798A (en) Method for direction estimation
AU6066999A (en) Method for identifying atrial natriuretic peptide (anp)
AU3981799A (en) Method for identifying genes
HUP0004619A3 (en) Method for preparing formylphosphonic acid
AU7063298A (en) Etching method
AUPP403098A0 (en) Method and system for selection candidates for employment
AU9013498A (en) Method for a bending procedure
AU1306200A (en) Method for transferring information
AU8009198A (en) Method for modifying wooden surfaces
ZA969671B (en) Method for renewing sliprings
AU7558998A (en) Method for reinforcing
AUPO937097A0 (en) Method
AUPO870297A0 (en) Method
AU8892598A (en) Method for creating images

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase